000			01180nam a2200121Ia 4500
008			220615s9999||||xx |||||||||||||| ||und||
245		0	_aGenomics and Models of Nerve Sheath Tumors
546			_aEnglish[eng]
650			_aneurofibromatosis type 1||nerve sheath tumor||cancer||latent variables||machine learning||supervised learning||transfer learning||random forest||metaVIPER||tumor deconvolution||neurofibromatosis||malignant peripheral nerve sheath tumor||MPNST||polycomb repressive complex||PRC2||NF1||kinase||kinome adaptation||kinome reprogramming||MET||MEK||doxorubicin||capmatinib||tram||genomics||tumor evolution||pathology||next generation sequencing||clinical genetics||malignant peripheral nerve sheath tumors||plexiform neurofibromas||Schwann cells||neurofibromatosis type 1 syndrome||neurofibromin 1||genetically engineered mouse models||heterogeneity||CRISPR/Cas9||mouse models||sarcoma||tumor microenvironment||neurofibromatosis 1 (NF1)||mebendazole (MBZ)||COX-2 inhibitor||malignancy||chemoprevention||nerve sheath tumors
700			_aHirbe, Angela C.||Pratilas, Christine A.||Dodd, Rebecca D.
856			_uhttps://mdpi.com/books/pdfview/book/3090
942			_cEB
999			_c16585 _d16585